Generic dupixent?

Short answer: There isn’t a generic version of Dupixent (dupilumab) available.

A few key points:
- Dupilumab is a monoclonal antibody (a biologic). For biologics, “generics” aren’t used; instead, companies pursue biosimilars.
- As of 2026, there are no FDA-approved dupilumab biosimilars in the United States.
- In other countries, biosimilars may exist or be in development, but availability varies by region.
- If cost or access is a concern, talk to your clinician or pharmacist about manufacturer patient assistance programs, insurance coverage, or potential alternative therapies.

If you’re asking about a specific country or want the latest status on biosimilars in your area, tell me your country and I can check (informally) what’s currently available.